Govorov A V, Sarukhanian A L
Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia.
Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia.
Urologiia. 2023 Sep(4):129-135.
The perioperative management of patients involves multiple aspects. Acute urinary retention (AUR) is one of the possible postoperative complications. Alpha-adrenoblockers are commonly used for treatment and prevention of AUR. Tamsulosin is the most often prescribed drug; there are a lot of studies devoted to its use in different patient subgroups. The aim of our study was to evaluate the efficiency of perioperative use of tamsulosin for the prevention of postoperative AUR. A literature review from January 2013 to June 2023 in Scopus and PubMed databases was carried out. According to the results, tamsulosin results in a significant reduction in the risk of postoperative AUR. A personalized approach allows to overcome difficulties in the perioperative management of patients and significantly improve their quality of life/satisfaction from treatment.
患者的围手术期管理涉及多个方面。急性尿潴留(AUR)是可能的术后并发症之一。α-肾上腺素能阻滞剂常用于治疗和预防AUR。坦索罗辛是最常处方的药物;有许多研究致力于其在不同患者亚组中的应用。我们研究的目的是评估围手术期使用坦索罗辛预防术后AUR的有效性。对Scopus和PubMed数据库中2013年1月至2023年6月的文献进行了综述。根据结果,坦索罗辛可显著降低术后AUR的风险。个性化方法有助于克服患者围手术期管理中的困难,并显著提高其生活质量/治疗满意度。